Dr Laurent Sabbagh to present at the 2nd annual GPCRs-targeted Drug Discovery Summit
Domain Therapeutics North America will participate to the 2nd annual GPCRs-targeted Drug Discovery Summit, meet our General Director Guy Le Houillier, and Scientific Director, Laurent Sabbagh.
Do not hesitate to attend Dr Laurent Sabbagh’s presentation “Early-Stage Development of BRET-Based Assays to Characterize the Activation of the Human Adhesion GPCR ADGRE5“ on February 22 at 9:15 am EST.
This presentation will give the possibility to understand how the bioSens-All® technology can help bring new light on challenging targets.
Dr Laurent Sabbagh is Scientific Director at Domain Therapeutics North America.